Form D · Other Health Care
Vivante Health, Inc.
Houston, TX · CIK 0001919280
Offering snapshot reported Mar 25, 2022 · SEC filing
- Reported sold
- $18.3M Offering amount: $18.3M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 22, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 25, 2022 | Initial | $18,278,190 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-439012
Includes Conversion of Convertible Promissory Notes converting to Series A Preferred Stock and Common Stock.
Source: Form D, filed Mar 25, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shawn Ellis | Director |
| Robert Garber | Director |
| William Snyder | Director, Executive |
| Sally Welborn | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2450 Holcombe Boulevard Suite J
Houston, TX, 77021
Houston, TX, 77021